COMPANY
Message from CEO
Company Profile
Mission, Vision, Values
Leadership
Advisory Team
TECHNOLOGY
Our technology
Pipeline
NEWS
RECRUIT
CONTACT US
JPN
COMPANY
TECHNOLOGY
NEWS
採用情報
CONTACT US
Privacy policy
News
Home
ENGNews
PR
(6)
2025/07/07
PR
A-SEEDS Closes ¥2.38 Billion (≈ USD 15 Million) Series A Financing to Accelerate Australian Clinical Trial of Its CAR-T Cell Therapy
2025/05/12
PR
First-in-Human Dosing Completed for A-SEEDS’ EPHB4-Targeted CAR-T Cell Product (Product Code: AP8901)
1
2
3
